Difference between revisions of "OctPGMSGp pathway control state"
From Bioblast
| Line 5: | Line 5: | ||
'''MitoPathway control:''' CI<small>&</small>II<small>&</small>FAO<small>&</small>GpDH | '''MitoPathway control:''' CI<small>&</small>II<small>&</small>FAO<small>&</small>GpDH | ||
'''SUIT protocol:''' [[SUIT | '''SUIT protocol:''' [[SUIT RP2]] | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
Revision as of 12:17, 20 July 2016
- high-resolution terminology - matching measurements at high-resolution
OctPGMSGp pathway control state
Description
PGMSOctGp: Pyruvate & Glutamate & Malate & Succinate & Octanoylcarnitine & Glycerophosphate.
MitoPathway control: CI&II&FAO&GpDH
SUIT protocol: SUIT RP2
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: PGMSOctGp
Reference: MiPNet21.06 SUIT reference protocol
MitoPedia concepts:
Respiratory state,
SUIT state
PGMSOctGp(L)
PGMSOctGp(P)
PGMSOctGp(E)
- SUIT RP2_8Gp: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
